Valneva and Pfizer report further positive Phase 2 data for Lyme disease vaccine candidate
Synopsis : Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE) today reported further positive…
Synopsis : Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE) today reported further positive…
Summary : Scientists from Ludwig-Maximilians-Universitaet (LMU) in Munich, Helmholtz Munich, and Technical University of Munich have shown that the immune system is…
Summary : Targa Resources Corp. (NYSE: TRGP) (“Targa” or the “Company”) announced today that it has executed agreements selling its wholly-owned subsidiary…
Summary : OceanFirst Financial Corp. (NASDAQ:”OCFC”), (the “Company”), the holding company for OceanFirst Bank N.A. (the “Bank”), today, announced the Company has signed…
Summary : -As Australians gear up for the further reopening of international travel lanes in 2022, proof of COVID-19 vaccination is a…
Global Crossing Airlines Group, Inc. (JET: TSX-V; JET.B: TSX-V; JETMF: OTCQB) (the “Company” or “GlobalX”) today announces that, on February 3, 2022 the…
Summary : First-ever lentiviral hematopoietic stem cell gene therapy approved for reimbursement by NHS England Two children with early-onset MLD recently treated…
Summary : On Thursday, Mersana Therapeutics signed a research and licensing deal with Janssen Biotech to access each other’s proprietary technology in…
Synopsis : A $1.5 billion diabetes partnership between Eli Lilly and China-based Regor Therapeutics Group is at the center of a lawsuit…
Synopsis : A new study published in the journal Nature found that two patients with leukemia who were treated with CAR T-cell…